Skip to content

Clinical trials

Completed Phase 3 Gastroesophageal Reflux trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastroesophageal Reflux Phase: Phase 3 Status: Completed Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20015
20021
20033
20046
20059
200614
20073
20087
20095
20103
20113
20123
20137
20163
20171
20181
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed78

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda13
AstraZeneca12
Wyeth is now a wholly owned subsidiary of Pfizer8
Eisai Inc.6
Reckitt Benckiser Healthcare (UK) Limited3
Ahn-Gook Pharmaceuticals Co.,Ltd2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Novartis2
Seoul National University Hospital2
Associated Scientists to Help Minimize Allergies1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastroesophageal Reflux78
Heartburn14
Dyspepsia4
Abdominal Pain2
Asthma2
Disease2
Esophageal Diseases2
Esophagitis, Peptic2
Bronchiectasis1
Bronchitis, Chronic1

Trials

Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.